PriceTargets.com logo

Health In Tech - HIT Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $2.50
  • Forecasted Upside: 96.85%
  • Number of Analysts: 2
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 1 Strong Buy Ratings
$1.27 As of 12/4/2025 05:00 PM ET
▼ -0.02 (-1.55%)

This chart shows the closing price for HIT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Health In Tech Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HIT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HIT

Analyst Price Target is $2.50
▲ +96.85% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Health In Tech in the last 3 months. The average price target is $2.50, with a high forecast of $2.50 and a low forecast of $2.50. The average price target represents a 96.85% upside from the last price of $1.27.

This chart shows the closing price for HIT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 2 investment analysts is to moderate buy stock in Health In Tech. This rating has held steady since September 2025, when it changed from a Strong Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 1 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 1 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/4/2025
  • 1 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 1 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/8/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/27/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
6/26/2025Maxim GroupUpgradeStrong-Buy$2.50
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.34 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 5 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 2 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 3 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 3 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Health In Tech logo
Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.
Read More

Today's Range

Now: $1.27
Low: $1.17
High: $1.37

50 Day Range

MA: $2.54
Low: $1.25
High: $3.77

52 Week Range

Now: $1.27
Low: $0.51
High: $7.59

Volume

1,136,512 shs

Average Volume

1,027,759 shs

Market Capitalization

$72.27 million

P/E Ratio

42.33

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Health In Tech?

The following Wall Street research analysts have issued research reports on Health In Tech in the last twelve months: Maxim Group, Wall Street Zen, and Weiss Ratings.
View the latest analyst ratings for HIT.

What is the current price target for Health In Tech?

0 Wall Street analysts have set twelve-month price targets for Health In Tech in the last year. Their average twelve-month price target is $2.50, suggesting a possible upside of 96.9%. Maxim Group has the highest price target set, predicting HIT will reach $2.50 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $2.50 for Health In Tech in the next year.
View the latest price targets for HIT.

What is the current consensus analyst rating for Health In Tech?

Health In Tech currently has 1 sell rating and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for HIT.

What other companies compete with Health In Tech?

Other companies that are similar to Health In Tech include NI, James River Group, SelectQuote, Kingstone Companies and Roadzen. Learn More about companies similar to Health In Tech.

How do I contact Health In Tech's investor relations team?

Health In Tech's physical mailing address is 701 S. COLORADO AVE, SUITE 1, STUART, FL, 34994. The company's listed phone number is (888) 373-0333. The official website for Health In Tech is healthintech.com. Learn More about contacing Health In Tech investor relations.